Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the successful completion of its acquisition of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA).
Inc. (NSYE:PFE) today announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. (Nasdaq
Portola Pharmaceuticals Inc (PTLA) Q4 2024 Earnings Call Transcript. Here's Why Portola Pharmaceuticals Fell as Much as 45.4% Today. 3 Small-Cap Healthcare Stocks With Large-Cap Potential.
Portola Pharmaceuticals, Inc, et al, Case No. 3:20-cv- VC. District Portola Pharmaceuticals, Inc. Securities Litigation c/o Epiq Class
SOUTH SAN FRANCISCO, Calif, /PRNewswire/ - Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) (the Company or Portola
All persons and entities who purchased or otherwise acquired the common stock of Portola Pharmaceuticals, Inc. ( Portola Inc. ) between Janu and Febru, inclusive (the Settlement Class Period ), and were allegedly damaged thereby; including those who purchased or otherwise acquired Portola Inc. common stock either
Pharmaceuticals, Business Services, and Pharmaceutical Portola Pharmaceuticals Inc, Portola, Lexicon Pharmaceuticals, Inc, Portola Pharmaceuticals I.
Pharmaceutical, Inc.'s acquisition of Portola Pharmaceuticals, Inc. DUPONT and KAPLAN were arrested June 2024 and pled guilty before U.S.
The latest litigation news involving the company Portola Pharmaceuticals Inc. (NASDAQ:PTLA)
Comments
5star story.